Sho Ueda

Sho Ueda

Auto-generated profile, based on publicly available information

Sho Ueda

Department of Thoracic Surgery, University of Tsukuba , Ibaraki, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
SUSho Ueda
Sho Ueda
SYSatoshi Yamashita
Satoshi Yamashita
MNMiho Nakajima
Miho Nakajima
TKTadashi Kumamoto
Tadashi Kumamoto
COChitose Ogawa
Chitose Ogawa
TUToshikazu Ushijima
Toshikazu Ushijima
Somatic mutations are accumulated in normal human tissues with aging and exposure to carcinogens. If we can accurately count any passenger mutations in any single DNA molecule, since their quantity is much larger than driver mutations, we can sensitively detect mutation accumulation in polyclonal normal tissues. Duplex sequencing, which tags both DNA strands in one DNA molecule, enables accurate count of such mutations, but requires a very large number of sequencing reads for each single sample of human-genome size. Here, we reduced the genome size to 1/90 using the Bam HI restriction enzyme and established a cost-effective pipeline. The enzymatically cleaved and optimal sequencing (EcoSeq) method was able to count somatic mutations in a single DNA molecule with a sensitivity of as low as 3 × 10 −8 per base pair (bp), as assessed by measuring artificially prepared mutations. Taking advantages of EcoSeq, we analyzed normal peripheral blood cells of pediatric sarcoma patients who received chemotherapy ( n = 10) and those who did not ( n = 10). The former had a mutation frequency of 31.2 ± 13.4 × 10 −8 per base pair while the latter had 9.0 ± 4.5 × 10 −8 per base pair ( P < 0.001). The increase in mutation frequency was confirmed by analysis of the same patients before and after chemotherapy, and increased mutation frequencies persisted 46 to 64 mo after chemotherapy, indicating that the mutation accumulation constitutes a risk of secondary leukemia. EcoSeq has the potential to reveal accumulation of somatic mutations and exposure to environmental factors in any DNA samples and will contribute to cancer risk estimation.

6 April 2021 in Epigenomics
Verified
Journal Article
Closed access
SUSho Ueda
Sho Ueda
SYSatoshi Yamashita
Satoshi Yamashita
SWShun-Ichi Watanabe
Shun-Ichi Watanabe
MWMika Wakabayashi
Mika Wakabayashi
NMNoriko Motoi
Noriko Motoi
TUToshikazu Ushijima
Toshikazu Ushijima
Aim: Depending upon the degree of DNA degradation of formalin-fixed and paraffin-embedded tissue samples, accuracy of measurement by Infinium MethylationEPIC BeadChip assay (Illumina, CA, USA) was ...

1 July 2023 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
YSYusuke Saeki
Yusuke Saeki
JOJunko Okamura
Junko Okamura
SUSho Ueda
Sho Ueda
YSYukio Sato
Yukio Sato
European Journal of Cardio-Thoracic Surgery thanks Stefano Bongiolatti, Dominique Gossot and the other, anonymous reviewer(s) for their contribution to the peer review process of this article. ...